MRK - CIK 0000310158
Merck & Co., Inc. (MRK) reported net income of $17.12B for fiscal year 2024, up 4589.6% from $365.00M in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
| Quarter | Period end | net income |
|---|---|---|
| Q1 | 2024-03-31 | $4.76B |
| Q2 | 2024-06-30 | $5.46B |
| Q3 | 2024-09-30 | $3.16B |
Calendar quarters as standardized by SEC XBRL frames; the company's fiscal calendar may offset from calendar quarters.
Merck & Co., Inc. (MRK) reported net income of $17.12B for fiscal year 2024, up 4589.6% from $365.00M in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
In the following fiscal year (2025), Merck & Co., Inc. reported net income of $18.25B, an increase from the $17.12B reported in fiscal 2024.
See the full MRK net income history or the complete income statement.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.